Rose Limaye


Rose Limaye


London | 160 Queen Victoria Street, London EC4V 4QQ
+44 20 7184 7448 | +44 20 7184 7001

| vCard | PDF

Rose Limaye focuses her practice on corporate and securities matters with an emphasis on corporate transactions, including mergers and acquisitions, fundraisings, public offerings, and reorganizations.

Ms. Limaye joined Dechert in 2015 as a trainee and qualified in 2017.


  • Prexton Therapeutics B.V. and its selling shareholders, including M Ventures, in its sale to global pharmaceutical company H. Lundbeck A/S for up to €905 million.
  • The shareholders on the sale of Stat-Dx, a privately owned Spanish diagnostics company, to QIAGEN N.V., for US$191 million (including milestones).  
  • University of Oxford, B.A., 2014
  • University of Law, Legal Practice Course, 2015